Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how 10x Genomics, Inc. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $642.82M | $610.78M | $618.73M | $516.41M | $490.49M | $298.85M | $245.89M | $146.31M | $71.08M |
| Revenue Growth? | +5.2% | -1.3% | +19.8% | +5.3% | +64.1% | +21.5% | +68.1% | +105.8% | 0.0% |
| Cost of Revenue? | $198.94M | $196.30M | $209.41M | $120.39M | $74.09M | $58.47M | $61.03M | $28.66M | $10.56M |
| Gross Profit? | $443.88M | $414.48M | $409.31M | $396.02M | $416.40M | $240.38M | $184.86M | $117.65M | $60.52M |
| Gross Margin? | +69.1% | +67.9% | +66.2% | +76.7% | +84.9% | +80.4% | +75.2% | +80.4% | +85.1% |
| Operating Expenses? | $554.77M | $609.04M | $674.64M | $563.97M | $469.31M | $325.70M | $213.93M | $135.47M | $78.90M |
| Operating Income? | -$110.89M | -$194.56M | -$265.33M | -$167.94M | -$52.91M | -$85.32M | -$29.07M | -$110.76M | -$18.38M |
| EBITDA? | -$110.89M | -$133.99M | -$205.11M | -$128.49M | -$24.59M | -$513.77M | -$20.89M | -$106.08M | -$13.63M |
| Income Before Tax | -$39.91M | -$177.70M | -$248.76M | -$161.97M | -$53.72M | -$534.48M | -$31.03M | -$112.40M | -$18.74M |
| Income Tax Expense | $3.64M | $4.93M | $6.34M | $4.03M | $4.51M | $8.26M | $218,000 | $87,000 | $21,000 |
| Net Income? | -$43.54M | -$182.63M | -$255.10M | -$166.00M | -$58.22M | -$542.73M | -$31.25M | -$112.48M | -$18.76M |
| EPS? | $-0.35 | $-1.52 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-8.40 | $-1.62 |
| Diluted EPS? | $-0.35 | $-1.52 | $-2.18 | $-1.46 | $-0.53 | $-5.37 | $-0.80 | $-8.40 | $-1.62 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality